{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:52:42Z","timestamp":1772808762171,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T00:00:00Z","timestamp":1194566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>SUMMARY:<\/jats:title><jats:p><jats:bold>Background:\u2003<\/jats:bold> Cyclosporine\u2010induced side\u2010effects such as gum enlargement and hirsutism potentially limit its effectiveness as a calcineurin\u2010antagonist if these effects contribute to a lack of compliance. Although the differences in incidence of these effects are widely recognized, few studies are available to show the extent of reduced gum enlargement and hirsutism in patients converted from cyclosporine to tacrolimus. This study aimed to determine the efficacy and safety and patient\u2010reported outcomes of such conversions.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> Twenty\u2010one consecutive cyclosporine\u2010treated renal\u2010transplant recipients with evidence of gingival enlargement were randomized into two arms: 10 continued to receive cyclosporine, 11 were converted to tacrolimus. Mean differences (0\u20133, 0\u20136, 0\u20139 and 0\u201312\u2003months) in periodontal indices (gingival inflammation, plaque, pocket depth, gingival enlargement), hirsutism, serum creatinine and glucose and subjective differences in the patient's rating of disfigurement due to hirsutism and gingival enlargement were recorded.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> There were no differences in baseline periodontal scores between the two groups. Tacrolimus\u2010treated subjects had significantly reduced pocket depth and gingival enlargement measures (Pocket Depths: \u22120.40\u2003\u00b1\u20030.58 <jats:italic>vs<\/jats:italic> 0.30\u2003\u00b1\u20030.35, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01; Gingival Enlargement Index: \u22121.12\u2003\u00b1\u20030.83 <jats:italic>vs<\/jats:italic>\u22120.10\u2003\u00b1\u20030.89, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05; tacrolimus <jats:italic>vs<\/jats:italic> cyclosporine, respectively), and decreased subjective disfigurement compared with the cyclosporine\u2010treated group over the 12\u2003months. While there was no difference in objective hirsutism scores between the two groups, tacrolimus\u2010treated patients reported a significant improvement and cyclosporine\u2010treated patients a significant worsening in their degree of disfigurement at the end of 12\u2003months. There were no differences in creatinine or glucose levels.<\/jats:p><jats:p><jats:bold>Conclusion:\u2003<\/jats:bold> Conversion from cyclosporine to tacrolimus in stable renal\u2010transplant recipients with cyclosporine\u2010induced gingival enlargement can be achieved safely and with measurably good effect.<\/jats:p>","DOI":"10.1111\/j.1440-1797.2007.00884.x","type":"journal-article","created":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T11:02:41Z","timestamp":1194606161000},"page":"607-614","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Conversion of cyclosporine to tacrolimus in stable renal allograft recipients: Quantification of effects on the severity of gingival enlargement and hirsutism and patient\u2010reported outcomes"],"prefix":"10.1111","volume":"12","author":[{"given":"ROWAN G","family":"WALKER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEPHEN","family":"COTTRELL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KATHLEEN","family":"SHARP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROSAMARIA","family":"TRIPODI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KATHY M","family":"NICHOLLS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IAN","family":"FRASER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GEORGE A","family":"VARIGOS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BELINDA E","family":"BUTCHER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","unstructured":"ChisholmMA LanceCE MulloyLL.Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients.Am. J. Health Syst. Pharm.2005;62:1775\u201381.","DOI":"10.2146\/ajhp040541"},{"key":"e_1_2_7_3_2","unstructured":"MihatschMJ KyoM MorozumiK YamaguchiY NickeleitV RyffelB.The side\u2010effects of ciclosporine\u2010A and tacrolimus.Clin. Nephrol.1998;49:356\u201363."},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","unstructured":"TanabeK.Calcineurin inhibitors in renal transplantation: What is the best option?Drugs2003;63:1535\u201348.","DOI":"10.2165\/00003495-200363150-00002"},{"key":"e_1_2_7_5_2","doi-asserted-by":"crossref","unstructured":"Sanson\u2010FisherRW PerkinsJJ.Adaptation and validation of the SF\u201036 Health Survey for use in Australia.J. Clin. Epidemiol.1998;51:961\u20137.","DOI":"10.1016\/S0895-4356(98)00087-0"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","unstructured":"LoeeH SilnessJ.Periodontal disease in pregnancy. I. Prevalence and severity.Acta Odontol. Scand.1963;21:533\u201351.","DOI":"10.3109\/00016356309011240"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","unstructured":"SilnessJ LoeeH.Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition.Acta Odontol. Scand.1964;22:121\u201335.","DOI":"10.3109\/00016356408993968"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","unstructured":"KingGN FullinfawR HigginsTJ WalkerRG FrancisDM WiesenfeldD.Gingival hyperplasia in renal allograft recipients receiving cyclosporin\u2010A and calcium antagonists.J. Clin. Periodontol.1993;20:286\u201393.","DOI":"10.1111\/j.1600-051X.1993.tb00360.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","unstructured":"McGawT LamS CoatesJ.Cyclosporin\u2010induced gingival overgrowth: Correlation with dental plaque scores gingivitis scores and cyclosporin levels in serum and saliva. [Erratum appears inOral Surg Oral Med Oral PatholJune 1988; 65: 684.]Oral Surg. Oral Med. Oral Pathol.1987;64:293\u20137.","DOI":"10.1016\/0030-4220(87)90007-7"},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","unstructured":"SeymourRA SmithDG TurnbullDN.The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients.J. Clin. Periodontol.1985;12:413\u201319.","DOI":"10.1111\/j.1600-051X.1985.tb01377.x"},{"key":"e_1_2_7_11_2","volume-title":"International Statistical Classification of Diseases and Related Health Problems","author":"World Health Organization.","year":"2003"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2005.00154.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2000.71.10.1630"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)00560-0"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2005.76.8.1259"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.5005\/jcdp-4-1-10"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1397-3142.2003.00067.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0765.2003.00383.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199806270-00012"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07875-3"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199712270-00020"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000139253.30998.57"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1797.2007.00884.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1797.2007.00884.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T19:22:30Z","timestamp":1697138550000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1797.2007.00884.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,9]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1440-1797.2007.00884.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1797.2007.00884.x","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,9]]},"assertion":[{"value":"2007-11-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}